20/20 Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.53M Buy
15,384
+92
+0.6% +$15.2K 0.66% 37
2021
Q1
$2.51M Buy
15,292
+106
+0.7% +$17.2K 0.73% 36
2020
Q4
$2.45M Buy
15,186
+11,638
+328% +$1.72M 0.72% 38
2020
Q3
$528K Buy
3,548
+1
+0% +$148 0.2% 86
2020
Q2
$527K Sell
3,547
-64
-2% -$9.33K 0.2% 80
2020
Q1
$533K Sell
3,611
-86
-2% -$12.2K 0.24% 78
2019
Q4
$568K Buy
+3,697
New +$501K 0.23% 76

Other funds holding JNJ

20/20 Capital Management's JNJ Position: Q2 2021 in Review

20/20 Capital Management increased its Johnson & Johnson (JNJ) stake by 0.6% in Q2 2021, buying an estimated $15.2K and bringing the position to 15,384 shares worth $2.53M. The position accounts for 0.66% of the portfolio, ranked #37.

20/20 Capital Management first reported a position in JNJ in Q4 2019 and has held it in 7 quarters since. 3,327 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.

  • 20/20 Capital Management held 15,384 shares of Johnson & Johnson worth $2.53M as of Q2 2021.
  • 20/20 Capital Management bought 92 Johnson & Johnson shares in Q2 2021, an estimated $15.2K.
  • Johnson & Johnson made up 0.66% of 20/20 Capital Management's portfolio in Q2 2021, its #37 holding.
  • 20/20 Capital Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 7 quarters since.
  • 3,327 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.

Based on 20/20 Capital Management's 13F filing for Q2 2021, filed 12 Jul 2021.